Company plans to file its Earnings Report on August 14, 2025 on Form 10-Q for the quarter ended June 30, 2025
Jaguar CEO Lisa Conte presenting August 20 at Emerging Growth Conference to provide updates on near-term catalysts; Click here to register
SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / August 12, 2025 / Jaguar Health, Inc.(NASDAQ:JAGX) today announced that the company will conduct an investor webcast on Thursday, August 14, 2025, at 8:30 a.m. Eastern to review second-quarter 2025 financials and provide corporate updates.
Participation Instructions for Jaguar Investor Webcast
When: Thursday, August 14, 2025 at 8:30 AM Eastern Time
Participant Registration & Access Link: Click Here
Participation Instructions for Jaguar’s Virtual Presentation at the Emerging Growth Conference
When: Wednesday, August 20, 2025 from 2:55 – 3:05 PM Eastern Time
Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Napo’s crofelemer is FDA-approved under the brand name Mytesi® for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan diseases. Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar’s Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications.
Certain statements in this press release constitute “forward-looking statements.” These include statements regarding the expectation that Jaguar will file its 10-Q on August 14, 2025 for the quarter ended June 30, 2025, the expectation that Jaguar will hold an investor webcast on August 14, 2025, and Jaguar’s expectation that Jaguar management will present at the August 2025 Emerging Growth Conference. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “aim,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar’s control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.
Manuscript accepted for publication in Frontiers in Pharmacology, “Oral Administration of Ketamir-2, a Novel Ketamine Analog, Attenuates Neuropathic Pain in Rodent Models via Selective NMDA Antagonism” details Ketamir-2’s superior performance in two validated neuropathic pain models and supports advancement to Phase 2a clinical trials by year-end 2025.
MIAMI, FL / ACCESS Newswire / August 12, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) (“MIRA” or the “Company”), a clinical-stage pharmaceutical company developing novel oral therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced the acceptance of a second peer-reviewed manuscript describing its lead oral drug candidate, Ketamir-2, in Frontiers in Pharmacology.
The newly accepted publication reports that Ketamir-2 outperformed ketamine, pregabalin, or gabapentin-depending on the comparator used-in restoring sensory function and reversing pain behaviors across two gold-standard rodent models of neuropathic pain. The findings build on MIRA’s first publication characterizing Ketamir-2’s clean pharmacology and favorable safety profile and align with the Company’s plan to initiate a Phase 2a trial in neuropathic pain by year-end 2025.
Market Opportunity
Neuropathic pain represents a significant and underserved market across North America. Epidemiology suggests approximately 7-10% of the population experiences neuropathic pain; in North America, this equates to approximately 36-51 million people across the U.S., Canada, and Mexico. According to Precedence Research, the global neuropathic pain market is valued at approximately $7.97 billion in 2024 and is projected to reach $16.79 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.73%. North America accounts for a significant share of this market, representing an estimated $3.7-3.9 billion annually today. The U.S. neuropathic pain market is estimated at $2.79 billion in 2024 and is projected to reach $5.92 billion by 2034, growing at a CAGR of 7.80% over the same period. Growth is expected to be driven by rising prevalence of diabetes, cancer survivorship, and aging-related nerve damage, underscoring the large and expanding commercial potential for novel treatments such as Ketamir-2.
Ketamir-2’s differentiated mechanism, oral bioavailability, and superior performance in gold-standard preclinical models position it as a potential next-generation, non-opioid treatment option in this multi-billion-dollar and rapidly growing market.
Key Findings from the Publication
Chung Model (sciatic nerve ligation in rats)
Male rats: Ketamir-2 restored sensory thresholds toward baseline, while ketamine-tested as the comparator-showed no measurable benefit.
Female rats: Ketamir-2 outperformed both pregabalin and gabapentin, delivering greater and more consistent restoration of normal sensory responses.
Paclitaxel (PTX)-Induced Neuropathy in Mice
Gabapentin was the sole comparator in this chemotherapy-induced neuropathy model. Ketamir-2 produced more complete normalization of pain sensitivity in both male and female cohorts, while gabapentin provided only partial or inconsistent relief.
Efficacy Across Genders and Species Despite differences in baseline pain sensitivity between male and female animals, Ketamir-2 demonstrated clear and significant therapeutic benefit in every cohort tested.
Mechanistic Differentiation
Ketamir-2 is a new molecular entity that selectively binds to the PCP site of the NMDA receptor with low affinity and shows no significant interaction with over 40 other receptor systems, including serotonin, dopamine, and opioid receptors. This combination of selectivity, oral bioavailability, and demonstrated efficacy in gold-standard models suggests the potential for a differentiated, next-generation therapeutic option in neuropathic pain.
“The acceptance of this second peer-reviewed publication is another important milestone for our Ketamir-2 program,” said Erez Aminov, CEO of MIRA. “The data clearly demonstrate superior and more consistent pain relief compared to leading neuropathic pain drugs, within the specific models tested. This provides additional confidence as we advance Ketamir-2 toward Phase 2a clinical evaluation and continue to explore its potential in broader CNS applications.”
“The robust reversal of pain sensitivity observed in these well-validated preclinical models-whether compared to ketamine, pregabalin, or gabapentin-further supports Ketamir-2’s potential as a differentiated, orally administered treatment for neuropathic pain,” added Dr. Itzchak Angel, Chief Scientific Advisor. “Given the limited number of effective oral treatments for this indication, Ketamir-2’s profile is especially compelling.”
Clinical Development Update
Phase 1 Trial Progressing: The ongoing Phase 1 trial of Ketamir-2 in Israel is on schedule, with no safety concerns reported to date and the single ascending dose portion nearing completion.
Phase 2a by Year-End: MIRA plans to submit a Phase 2a clinical trial protocol to the U.S. Food and Drug Administration (FDA) in Q4 2025 as an advanced development version to its active IND, with the goal of initiating the study in neuropathic pain by year-end.
Potential Beyond Neuropathic Pain: With its clean pharmacology and oral bioavailability, Ketamir-2 is also being explored for potential applications in depression, anxiety, post-traumatic stress disorder (PTSD), and as a topical formulation for localized pain conditions.
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for neurologic, neuropsychiatric, and metabolic disorders. The Company’s pipeline includes oral drug candidates designed to address significant unmet medical needs in areas such as neuropathic pain, inflammatory pain, obesity, addiction, anxiety, and cognitive decline.
This press release and the statements of MIRA’s management related thereto contain “forward-looking statements,” which are statements other than historical facts made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may be identified by words such as “aims,” “anticipates,” “believes,” “could,” “estimates,” “expects,” “forecasts,” “goal,” “intends,” “may,” “plans,” “possible,” “potential,” “seeks,” “will,” and variations of these words or similar expressions that are intended to identify forward-looking statements. Any statements in this press release that are not historical facts may be deemed forward-looking. Any forward-looking statements in this press release are based on MIRA’s current expectations, estimates, and projections only as of the date of this release and are subject to a number of risks and uncertainties (many of which are beyond MIRA’s control) that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements, including related to MIRA’s potential merger with SKNY Pharmaceuticals, Inc. These and other risks concerning MIRA’s programs and operations are described in additional detail in the Annual Report on Form 10-K for the year ended December 31, 2024, and the Form 14A filed by MIRA on June 18, 2025, and other SEC filings, which are on file with the SEC at www.sec.gov and on MIRA’s website at https://www.mirapharmaceuticals.com/investors/sec-filings. MIRA explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.
MONTREAL, QC / ACCESS Newswire / August 12, 2025 / Vision Marine Technologies Inc. (NASDAQ:VMAR) (“Vision Marine” or the “Company”), a leader in electric marine propulsion and multi-brand boat retail, today announced a significant increase in sales performance-highlighted by accelerated boat sales revenue, a significant reduction in floor plan liabilities, and stronger inventory turnover-following the recent acquisition of Nautical Ventures Group Inc. (“Nautical Ventures”).
From June 20, 2025 to August 8, 2025, the newly acquired Nautical Ventures division generated approximately US$8.2 million in gross revenue through boat sales-compared to Vision Marine’s total boat sales of $1.4 million for its entire fiscal year ended August 31, 2024. This short-term performance reflects a 504% increase relative to the Company’s prior full-year sales and highlights the transformational impact of the acquisition, expanded retail footprint and integrated sales infrastructure.
This top-line expansion was accompanied by a 44% reduction in floor plan financing, declining from approximately US$56.1 million as of December 31, 2024, to US$31.3 million as of August 8, 2025. This reduction underscores Vision Marine’s focus on financial discipline, operational streamlining, and enhanced sales execution.
Inventory turnover has also accelerated. Between June 20, 2025 and August 8, 2025, the Company reduced its product inventory by approximately US$4.9 million, driven by increased demand across both internal combustion engine (“ICE”) and electric boat categories.
Vision Marine is also expanding into the tender boat segment. As announced in July, the Company is leveraging Nautical Ventures’ role as a leading U.S. distributor of Highfield Boats, which sold more than 600 tenders from 2022 to 2024 and generated over $14 million in related revenue. A new dedicated Fort Lauderdale facility now serves as a high-volume hub for tender sales and service.
In parallel, the Company saw a 900% year-over-year increase in inbound boat leads through the addition of Nautical Ventures’ sales channels, attributed to the availability of new product lines and a performance-driven marketing strategy. This demand directly supports Vision Marine’s growth across both electric and ICE segments.
“We want to be clear with investors: this is a materially different Vision Marine than it was last year,” said Alexandre Mongeon, CEO of Vision Marine. “Through the acquisition of Nautical Ventures, we’ve added real sales volume, operational scale, and a platform capable of accelerating both electric and traditional boat sales.”
Vision Marine will provide additional updates on its financial results and strategic milestones in its Q4 2025 release in November.
Preliminary and Unaudited Financial Information
The financial information presented in this release is preliminary, unaudited, and subject to change. These results have not been reviewed by the Company’s independent registered public accounting firm and may differ materially from results to be included in the Company’s upcoming filings with the U.S. Securities and Exchange Commission (“SEC”).
Use of Non-GAAP Financial Measures
This press release includes references to “gross revenue,” which may be considered a non-GAAP financial measure. Management uses this metric internally to evaluate performance; however, it should not be viewed as a substitute for, or superior to, measures calculated in accordance with IFRS. A reconciliation to GAAP financial measures will be provided, as necessary, in future filings with the SEC.
This press release may contain “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These statements reflect current expectations and projections about future events and are not guarantees of future performance. Actual results may differ materially from those expressed or implied due to various risks and uncertainties, including, but not limited to, integration risks related to the acquisition of Nautical Ventures, market demand, and operational execution. Vision Marine undertakes no obligation to update or revise any forward-looking statements except as required by law.
Investor and Company Contact: Bruce Nurse Investor Relations (303) 919‑2913 bn@v‑mti.com
Operational Efficiencies Improve, Increasing EBITDA and Cash Flow
Revenue increased 3% to $5.6M compared to $5.5M in Q1 2025 and decreased 7% from $6.0M in Q2 2024
Adjusted EBITDA increased $308,000 to $836,000 compared to $528,000 in Q2 2024
The Company was cash flow positive for the quarter, with cash flow from operations increasing $325,000 from Q2 2024
Subscriptions increased to 971 at the end of Q2 2025 from 955 at the end of Q1 2025 and 867 in Q2 2024
RALEIGH, NC / ACCESS Newswire / August 12, 2025 / ACCESS Newswire Inc. (NYSE American:ACCS) (the “Company”), a leading communications company, today reported its operating results for the three and six months ended June 30, 2025.
“We’re pleased to report another quarter of sequential growth, highlighting the continued momentum of our business as we execute on our long-term strategy,” said Brian R. Balbirnie, ACCESS Newswire’s Founder and Chief Executive Officer. “We continue to transition the business to a subscription-based model and remain confident this shift is delivering greater value to our customers while building a sustainable, predictable business that will be best for all stakeholders. We continue to see strong gross margins, an increase in the number of subscription customers and a return of adjusted EBITDA to mid-teen percentages of revenue, at 15% for the quarter. Along with increasing revenue, all of these remain key areas of focus through the remainder of the year.”
Mr. Balbirnie added, “Based on the breadth of our product functionality and our subscription-based approach, we are in a unique position to capture growth in the communications market and are excited about the upcoming product enhancements we will release as we approach the end of the year. Alongside our focus on continued operational efficiencies, we believe our initiatives will further strengthen our performance and drive improved results in both the near and long term.”
Second Quarter 2025 Highlights:
Revenue – Total revenue was $5,621,000, a 7% decrease from $6,020,000 in Q2 2024 and a 3% increase from $5,476,000 in Q1 2025. The decrease in revenue year-over-year is due to slight declines across all our various product lines, including revenue from our core press release business, which decreased 4% from the prior year due to lower revenue per release as a result of product mix, despite an increase in volume. Press release revenue increased 5% from Q1 2025.
Gross Margin – Gross margin for Q2 2025 was $4,285,000, or 76% of revenue, compared to $4,647,000, or 77% of revenue, during Q2 2024 and $4,273,000, or 78% of revenue in Q1 2025. The decrease from the prior year is primarily due to lower revenue, as costs of revenue remained consistent. The decrease from Q1 2025 is due to increased distribution costs with the addition of new distribution partners.
Operating Loss – Operating loss was $249,000 for Q2 2025, as compared to $531,000 during Q2 2024. Operating expenses decreased $644,000, or 12%, to $4.5 million. The decrease was primarily due to a reduction in headcount throughout the organization along with other initiatives to generate operational efficiencies.
Loss from continuing operations – On a GAAP basis, net loss from continuing operations was $239,000, or $0.06 per diluted share, for the three months ended June 30, 2025, compared to $683,000, or $0.18 per diluted share, for the three months ended June 30, 2024.
Net loss from discontinued operations, net of tax – On a GAAP basis, net loss from discontinued operations was $236,000, or $0.06 per diluted share during Q2 2025, compared net income from discontinued operations of $690,000, or $0.18 per diluted share during Q2 2024. The net loss from discontinued operations during Q2 2025 was primarily related to additional reserves on remaining accounts receivable.
Operating Cash Flows – Cash flows from operations for Q2 2025 were $135,000 compared to $(190,000) in Q2 2024.
Non-GAAP Measures – Q2 2025 EBITDA was $480,000, or 9%, compared to $211,000, or 4%, during Q2 2024. Adjusted EBITDA was $836,000, or 15% of revenue, for Q2 2025 compared to $528,000, or 9% of revenue, for Q2 2024. Non-GAAP net income for Q2 2025 was $556,000, or $0.14 per diluted share, compared to $101,000, or $0.03 per diluted share, during Q2 2024. Adjusted free-cash flow was $250,000 for Q2 2025 compared to $(292,000) for Q2 2024. The improvement to Non-GAAP measures is largely due to the cost improvements and operational efficiencies made in the business.
First Half 2025 Highlights:
Revenue – Total revenue was $11,097,000, a 4% decrease from $11,592,000 during the first half of 2024. Similar to the results for the quarter, the decrease was primarily due to declines in revenue across all of our product lines. Specifically, press release revenue decreased approximately 2% due to lower revenue per release as a result of product mix, on increased volumes.
Gross Margin – Gross margin for the first half of 2025 was $8,557,000, or 77% of revenue, compared to $8,831,000, or 76% of revenue, during the first half of 2024. The increase in gross margin percentage is due to the optimization of our operations team partially offset by increased distribution costs related to the addition of new partners.
Operating Loss – Operating loss was $926,000 for the first half of 2025, as compared to $1,393,000 during the first half of 2024. Operating expenses decreased $740,000, or 7%, to $9.5 million. As with the quarter, the decrease was primarily due to a reduction in headcount and operational efficiencies throughout the organization.
Loss from continuing operations – On a GAAP basis, net loss from continuing operations was $1,004,000, or $0.26 per diluted share during the first half of 2025, compared to $1,466000, or $0.38 per diluted share during the first half of 2024.
Net income from discontinued operations, net of tax – On a GAAP basis, net income from discontinued operations was $5,916,000, or $1.54 per diluted share during the first half of 2025, compared to $1,334,000, or $0.35 per diluted share during the first half of 2024. The increase was primarily due to the gain recorded on the sale of the compliance business of approximately $6.0M, net of taxes.
Operating Cash Flows – Cash flows from operations for the first half of 2025 were $882,000 compared to $796,000 during the first half of 2024.
Non-GAAP Measures – EBITDA for the first half of 2025 was $476,000, or 4%, compared to $282,000, or 2% of revenue, during the first half of 2024. Adjusted EBITDA was $1,400,000, or 13% of revenue, for the first half of 2025 compared to $415,000, or 4% of revenue, for the first half of 2024. Non-GAAP net income for the first half of 2025 was $762,000, or $0.20 per diluted share, compared to $(265,000), or $(0.07) per diluted share, during the first half of 2024. Adjusted free-cash flow was $1,217,000 for the first half of 2025 compared to $491,000 for first half of 2024. The improvement to Non-GAAP measures is largely due to the cost improvements and operational efficiencies made in the business.
Key Performance Indicators:
As of June 30, 2025, we had 11,770 customers who had an active contract during the past twelve months, compared to 12,112 as of June 30, 2024.
Subscription customers increased year-over-year by 104 to 971
Average ARR for subscriptions per customer at the end of the quarter was $11,039, up from $10,068 as of June 30, 2024.
Non-GAAP Financial Measures
The non-GAAP adjustments referenced below and herein relate to the exclusion of stock-based compensation, amortization of acquisition-related intangible assets. and other expenses the Company believes to be non-recurring. A reconciliation of GAAP to non-GAAP historical financial measures has been provided in the tables at the end of this press release.
Management believes that the use of EBITDA from continuing operations, Adjusted EBITDA from continuing operations, non-GAAP net income (loss) from continuing operations, non-GAAP net income (loss) from continuing operations per share, free cash flow and adjusted free cash flow is helpful to its investors. These measures, which are referred to as non-GAAP financial measures, are not prepared in accordance with generally accepted accounting principles in the United States, or GAAP. Our management uses these non-GAAP financial measures as tools for financial and operational decision making and for evaluating our own operating results over different periods of time.
EBITDA from continuing operations is calculated by excluding depreciation and amortization, interest expense, net, and income taxes from the loss from continuing operations. Adjusted EBITDA also excludes certain other expenses which the Company believes to be non-recurring as well as the gain or loss on the change in fair value of our interest rate swap. Non-GAAP net income (loss) from continuing operations is calculated by excluding stock-based compensation expense and amortization expense for acquisition-related intangible assets from loss from continuing operations and certain other adjustments noted in the tables below. Non-GAAP net income (loss) from continuing operations per share is calculated by dividing non-GAAP net income (loss) from continuing operations by the weighted-average diluted shares outstanding as presented in the calculation of GAAP net income (loss) from continuing operations per share. Because of varying available valuation methodologies, subjective assumptions and the variety of equity instruments that can impact a company’s non-cash expenses, management believes that providing non-GAAP financial measures that exclude stock-based compensation expense allows for more meaningful comparisons between its operating results from period to period. For business combinations, management generally allocates a portion of the purchase price to intangible assets. The amount of the allocation is based on estimates and assumptions made by management and is subject to amortization. The amount of purchase price allocated to intangible assets and the term of its related amortization can vary significantly and are unique to each acquisition and thus management does not believe they are reflective of ongoing operations.
Free cash flow, a non-GAAP measure, represents cash flow from operating activities less purchase of property and equipment and capitalized software. Adjusted free cash flow also deducts certain cash payments which the Company believe to be non-recurring in nature. Management considers free cash flow and adjusted free cash flow to be liquidity measures that provide useful information to investors about the amount of cash generated or used by the business.
Non-GAAP financial measures may not provide information that is directly comparable to that provided by other companies in our industry, as other companies in the industry may calculate non-GAAP financial results differently. In addition, there are limitations in using non-GAAP financial measures because the non-GAAP financial measures are not prepared in accordance with GAAP, may be different from non-GAAP financial measures used by other companies and exclude expenses that may have a material impact on our reported financial results.
The presentation of non-GAAP financial information below and herein are not meant to be considered in isolation or as a substitute for the directly comparable financial measures prepared in accordance with GAAP. Investors should review the reconciliation of non-GAAP financial measures to the comparable GAAP financial measures included below and not rely on any single financial measure to evaluate our business.
RECONCILIATION OF SELECTED GAAP MEASURES TO NON-GAAP MEASURES ($ in ‘000’s, except per share amounts) CALCULATION OF EBITDA & ADJUSTED EBITDA
Three Months Ended June 30,
2025
2024
Amount
Amount
Net loss from continuing operations:
$
(239
)
$
(683
)
Adjustments:
Depreciation and amortization
739
728
Interest (income) expense, net
(11
)
303
Income tax benefit
(9
)
(137
)
EBITDA from continuing operations
480
211
Acquisition and/or integration costs (1)
72
42
Other non-recurring expenses (2)
95
38
Stock-based compensation expense (3)
189
237
Adjusted EBITDA from continuing operations:
$
836
$
528
Six Months Ended June 30,
2025
2024
Amount
Amount
Net loss from continuing operations:
$
(1,004
)
$
(1,466
)
Adjustments:
Depreciation and amortization
1,481
1,456
Interest expense, net
193
587
Income tax benefit
(194
)
(295
)
EBITDA from continuing operations
476
282
Acquisition and/or integration costs (1)
201
107
Other non-recurring expenses (2)
331
(132
)
Stock-based compensation expense (3)
392
158
Adjusted EBITDA from continuing operations:
$
1,400
$
415
(1)
This adjustment gives effect to one-time corporate projects, including acquisition, divestiture and integration related expenses, incurred during the periods.
(2)
For the three months ended June 30, 2025, this adjustment gives effect to the loss on the change in fair value of our interest rate swap of $10,000 and non-recurring fees of $85,000. For the six months ended June 30, 2025, this adjustment gives effect to the loss on the change in fair value of our interest rate swap of $79,000, as well as corporate re-brand costs of $132,000 and non-recurring fees of $120,000. For the three and six months ended June 30, 2024, this adjustment gives effect to a gain recorded on the change in fair value of our interest rate swap of $14,000 and $219,000, respectively, partially offset by one-time accounting fees, termination benefits and other non-recurring or unusual expenses of $52,000 and $87,000, respectively.
(3)
The adjustments represent stock-based compensation expense from continuing operations related to awards of stock options, restricted stock units, or common stock in exchange for services. Although we expect to continue to award stock in exchange for services, the amount of stock-based compensation is excluded as it is subject to change as a result of one-time or non-recurring projects. For the six months ended June 30, 2024, this amount includes a benefit as a result of the resignation of an executive officer.
CALCULATION OF NON-GAAP NET INCOME (LOSS)
Three Months Ended June 30,
2025
2024
Amount
Per diluted
share
Amount
Per diluted
share
Net loss from continuing operations:
$
(239
)
$
(0.06
)
$
(683
)
$
(0.18
)
Adjustments:
Amortization of intangible assets(1)
630
0.16
637
0.17
Stock-based compensation expense(2)
189
0.05
237
0.06
Other unusual items(3)
167
0.04
80
0.02
Discrete items impacting income tax expense(4)
16
–
30
0.01
Tax impact of adjustments(5)
(207
)
(0.05
)
(200
)
(0.05
)
Non-GAAP net income (loss) from continuing operations:
$
556
0.14
$
101
$
0.03
Weighted average number of common shares outstanding – diluted
3,857
3,823
Six Months Ended June 30,
2025
2024
Amount
Per diluted
share
Amount
Per diluted
share
Net loss from continuing operations:
$
(1,004
)
$
(0.26
)
$
(1,466
)
$
(0.38
)
Adjustments:
Amortization of intangible assets(1)
1,260
0.33
1,280
0.33
Stock-based compensation expense(2)
392
0.10
158
0.04
Other unusual items(3)
532
0.14
(25
)
0.00
Discrete items impacting income tax expense(4)
41
0.01
85
0.02
Tax impact of adjustments(5)
(459
)
(0.12
)
(297
)
(0.08
)
Non-GAAP net income (loss) from continuing operations:
$
762
0.20
$
(265
)
$
(0.07
)
Weighted average number of common shares outstanding – diluted
3,850
3,821
(1)
The adjustments represent the amortization of intangible assets related to acquired assets and companies.
(2)
The adjustments represent stock-based compensation expense from continuing operations related to awards of stock options, restricted stock units, or common stock in exchange for services. Although we expect to continue to award stock in exchange for services, the amount of stock-based compensation is excluded as it is subject to change as a result of one-time or non-recurring projects. For the six months ended June 30, 2024, this amount includes a benefit as a result of the resignation of an executive officer.
(3)
For the three months ended June 30, 2025, this adjustment gives effect to the loss on the change in fair value of our interest rate swap of $10,000 and non-recurring fees, including acquisition, integration and divestiture costs of $157,000. For the six months ended June 30, 2025, this adjustment gives effect to the loss on the change in fair value of our interest rate swap of $79,000, as well as corporate re-brand costs of $132,000 and non-recurring fees, including acquisition, integration and divestiture costs of $321,000. For the three and six months ended June 30, 2024, this adjustment gives effect to a gain recorded on the change in fair value of our interest rate swap of $14,000 and $219,000, respectively, partially offset by one-time accounting fees, termination benefits and other non-recurring or unusual expenses, including acquisition and integration expenses of $94,000 and $194,000, respectively.
(4)
This adjustment gives effect to discrete items that impact income tax expense. For the three and six months ended June 30, 2025 and 2024, this relates to additional expense associated with vesting of stock-based compensation awards.
(5)
This adjustment gives effect to the tax impact of all non-GAAP adjustments at the current Federal tax rate of 21%.
CALCULATION OF FREE CASH FLOW AND ADJUSTED FREE CASH FLOW
Three Months Ended June 30,
2025
2024
Net cash provided by operating activities (GAAP)
$
135
$
(190
)
Payments for purchase of fixed assets and capitalized software
–
(155
)
Free cash flow (Non-GAAP)
135
(345
)
Cash paid for acquisition and integration related items (1)
31
–
Cash paid for other unusual items (2)
84
53
Adjusted free cash flow (Non-GAAP)
$
250
$
(292
)
Six Months Ended June 30,
2025
2024
Net cash provided by operating activities (GAAP)
$
882
$
796
Payments for purchase of fixed assets and capitalized software
(35
)
(416
)
Free cash flow (Non-GAAP)
847
380
Cash paid for acquisition and integration related items (1)
118
23
Cash paid for other unusual items (2)
252
88
Adjusted free cash flow (Non-GAAP)
$
1,217
$
491
(1)
This adjustment gives effect to one-time corporate projects, including acquisition, divestiture and integration related expenses, paid during the periods.
(2)
For the three and six months ended June 30, 2025, this relates to payments related to our corporate re-brand and other non-recurring fees. For the three and six months ended June 30, 2024, this adjustment gives effect to one-time accounting fees , termination benefits and other non-recurring or unusual expenses.
Conference Call Information
To participate in this event, dial approximately 5 to 10 minutes before the beginning of the call.
We are ACCESS Newswire, a globally trusted Public Relations (PR) and Investor Relations (IR) solutions provider. With a focus on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands to connect with their audiences where it matters most. From startups and scale-ups to multi-billion-dollar global brands, we ensure your most important moments make an impact and resonate with your audiences. To learn more visit www.accessnewswire.com.
Forward-Looking Statements
Certain statements in this press release are “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company’s future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements. In particular, statements about the Company’s expectations, beliefs, plans, objectives, assumptions, future events or future performance contained in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “commit,” “estimate,” “predict,” “potential,” “outlook,” “guidance,” “target,” “goal,” “project,” “continue to,” “confident,” or the negative of those terms or other comparable terminology. The forward-looking statements in this press release include, among other things, our confidence that our shift from pay-as-you-go to a subscription-based model is building the sustainable, predictable business we have been working toward and our belief that our various initiatives will further strengthen our performance and drive improved results in both the near and long-term.
Please see the Company’s documents filed or to be filed with the Securities and Exchange Commission at www.sec.gov, including the Company’s Annual Reports filed on Form 10-K, including the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, and Quarterly Reports on Form 10-Q, and any amendments thereto for a discussion of certain important risk factors that relate to forward-looking statements contained in this report. The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company’s control. These and other important factors may cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. Any forward-looking statements are made only as of the date hereof, and unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
For Further Information: ACCESS Newswire Inc. Brian R. Balbirnie (919)-481-4000 brianb@accessnewswire.com
ACCESS NEWSWIRE INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share amounts)
June 30,
December 31,
2025
2024
ASSETS
(unaudited)
Current assets:
Cash and cash equivalents
$
4,111
$
4,103
Accounts receivable (net of allowance for doubtful accounts of $1,600 and $1,059,
respectively)
3,731
3,351
Other current assets
1,716
1,234
Current assets held for sale
116
1,338
Total current assets
9,674
10,026
Capitalized software (net of accumulated amortization of $3,789 and $3,644, respectively)
811
934
Fixed assets (net of accumulated depreciation of $813 and $914, respectively)
302
365
Right-of-use asset – leases
639
766
Other long-term assets
88
158
Goodwill
19,043
19,043
Intangible assets (net of accumulated amortization of $8,284 and $7,024, respectively)
10,716
11,976
Deferred tax asset
4,280
3,793
Non-current assets held for sale
–
3,577
Total assets
$
45,553
$
50,638
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
$
1,478
$
1,423
Accrued expenses
2,394
1,699
Income taxes payable
2,684
56
Current portion of long-term debt
870
4,000
Deferred revenue
4,741
4,743
Current liabilities held for sale
–
893
Total current liabilities
12,167
12,814
Long-term debt (net of debt discount of $61 and $70, respectively)
2,112
11,930
Lease liabilities – long-term
495
668
Deferred Tax Liability
73
–
Other long-term liabilities
18
–
Total liabilities
14,865
25,412
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.001 par value, 1,000,000 shares authorized, no shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively.
–
–
Common stock $0.001 par value, 20,000,000 shares authorized, 3,868,826 and 3,838,743 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively.
4
4
Additional paid-in capital
24,728
24,259
Other accumulated comprehensive loss
(97
)
(178
)
Retained earnings
6,053
1,141
Total stockholders’ equity
30,688
25,226
Total liabilities and stockholders’ equity
$
45,553
$
50,638
ACCESS NEWSWIRE INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (in thousands, except share and per share amounts)
For the Three Months Ended
For the Six Months Ended
June 30,
June 30,
June 30,
June 30,
2025
2024
2025
2024
Revenues
$
5,621
$
6,020
$
11,097
$
11,592
Cost of revenues
1,336
1,373
2,539
2,761
Gross profit
4,285
4,647
8,558
8,831
Operating costs and expenses:
General and administrative
1,752
1,842
3,705
3,481
Sales and marketing expenses
1,462
1,943
3,056
4,014
Product development
655
719
1,388
1,373
Depreciation and amortization
665
674
1,335
1,356
Total operating costs and expenses
4,534
5,178
9,484
10,224
Operating loss
(249
)
(531
)
(926
)
(1,393
)
Interest income (expense), net
11
(303
)
(193
)
(587
)
Other income (loss), net
(10
)
14
(79
)
219
Loss before taxes
(248
)
(820
)
(1,198
)
(1,761
)
Income tax benefit
(9
)
(137
)
(194
)
(295
)
Net loss from continuing operations
(239
)
(683
)
(1,004
)
(1,466
)
Net income (loss) from discontinued operations, net of tax
(236
)
690
5,916
1,334
Net income (loss)
$
(475
)
$
7
$
4,912
$
(132
)
Loss from continuing operations per share – basic
$
(0.06
)
$
(0.18
)
$
(0.26
)
$
(0.38
)
Loss from continuing operations per share – fully diluted
$
(0.06
)
$
(0.18
)
$
(0.26
)
$
(0.38
)
Income (loss) from discontinued operations per share – basic
$
(0.06
)
$
0.18
$
1.54
$
0.35
Income (loss) from discontinued operations per share – fully diluted
$
(0.06
)
$
0.18
$
1.54
$
0.35
Income (loss) per share – basic
$
(0.12
)
$
0.00
$
1.28
$
(0.03
)
Income (loss) per share – fully diluted
$
(0.12
)
$
0.00
$
1.28
$
(0.03
)
Weighted average number of common shares outstanding – basic
3,856
3,821
3,849
3,818
Weighted average number of common shares outstanding – fully diluted
3,857
3,823
3,850
3,821
ACCESS NEWSWIRE INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (in thousands)
For the Six Months Ended
June 30,
June 30,
2025
2024
Cash flows from operating activities:
Net income (loss)
$
4,912
$
(132
)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Gain on disposal of business
(8,974
)
–
Depreciation and amortization
1,509
1,540
Provision for credit losses
976
595
Deferred income taxes
(415
)
(72
)
Stock-based compensation expense
469
200
Non-cash interest adjustment on note payable
9
8
Changes in operating assets and liabilities:
Decrease (increase) in accounts receivable
(680
)
(928
)
Decrease (increase) in other assets
226
52
Increase (decrease) in accounts payable
131
(230
)
Increase (decrease) in income tax payable
2,626
12
Increase (decrease) in accrued expenses
419
(341
)
Increase (decrease) in deferred revenue
(326
)
92
Net cash provided by operating activities
882
796
Cash flows from investing activities:
Proceeds from Sale of Compliance Business
12,000
–
Capitalized software
(23
)
(400
)
Purchase of fixed assets
(12
)
(16
)
Net cash provided by (used in) investing activities
Stream Hatchet Partners with Ubisoft to Power Influencer Strategy for Tom Clancy’s Rainbow Six Siege X Launch
FRISCO, TEXAS / ACCESS Newswire / August 12, 2025 / Stream Hatchet an influencer marketing company and live streaming analytics platform and wholly-owned subsidiary of GameSquare Holdings (NASDAQ:GAME), (“GameSquare”, or the “Company”), today announced a strategic collaboration with Ubisoft to support the launch of Tom Clancy’s Rainbow Six Siege X.
Under the agreement, Stream Hatchet will drive influencer strategy and execution, leveraging its proprietary technology and data-driven talent discovery platform to activate creators at scale. The partnership is expected to contribute to GameSquare’s 2025 revenue, underscoring the growing demand for managed influencer services in high-impact game launches.
“We’re proud to partner with Ubisoft on one of the most anticipated releases in tactical gaming,” stated Justin Kenna, GameSquare’s CEO. “This collaboration reflects the strength of our platform and Stream Hatchet’s evolution from analytics to a full-service marketing engine capable of delivering value to customers on a global scale.”
Tom Clancy’s Rainbow Six Siege, one of the most iconic competitive shooter franchises, has attracted over tens of millions of registered players since its original launch in 2015. With Rainbow Six Siege X, Ubisoft is introducing the next evolution in the franchise-aimed at re-engaging loyal players while captivating a new generation of gaming audiences.
“Our team is excited to help bring Rainbow Six Siege X to life through cutting-edge influencer activations,” added Justin Smith, Chief Commercial Officer of Stream Hatchet. “Our platform provides the tools and insight needed to identify the right voices and maximize impact across streaming and social channels. It’s a natural fit for a launch of this scale.”
This partnership highlights Stream Hatchet’s ongoing expansion into managed services and campaign execution, laying the groundwork for future long-term SaaS and marketing engagements with top-tier publishers.
For more information about Stream Hatchet or to explore partnership opportunities, visit www.streamhatchet.com.
About Stream Hatchet
Stream Hatchet is the leading provider of data analytics for the live streaming industry. With a suite of services encompassing a user-friendly SaaS platform, custom reports, and strategic agency consulting, Stream Hatchet is a trusted guide for those navigating the dynamic landscape of live streaming. The company has up to 7 years of historical data with minute-level granularity from 20 platforms, Stream Hatchet provides stakeholders in the live-streaming industry with powerful insights to drive innovation and growth. Stream Hatchet partners with a diverse clientele – from video game publishers and marketing agencies to esports organizers and teams – who rely on the company’s cutting-edge data analytics to optimize their marketing strategies, secure lucrative sponsorships, enhance esports performance, and build successful tournaments.
GameSquare (NASDAQ:GAME) is a cutting-edge media, entertainment, and technology company transforming how brands and publishers connect with Gen Z, Gen Alpha, and Millennial audiences. With a platform that spans award-winning creative services, advanced analytics, and FaZe Clan, one of the most iconic gaming organizations, we operate one of the largest gaming media networks in North America. Complementing our operating strategy, GameSquare operates a blockchain-native Ethereum treasury management program designed to generate onchain yield and enhance capital efficiency, reinforcing our commitment to building a dynamic, high-performing media company at the intersection of culture, technology, and next-generation financial innovation.
This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate, among other things, to: the Company’s and FaZe Media Inc.’s future performance, revenue, growth and profitability; and the Company’s and FaZe Media’s ability to execute their business plans. These forward-looking statements are provided only to provide information currently available to us and are not intended to serve as and must not be relied on by any investor as, a guarantee, assurance or definitive statement of fact or probability. Forward-looking statements are necessarily based upon a number of estimates and assumptions which include, but are not limited to: the Company’s and FaZe Media’s ability to grow their business and being able to execute on their business plans, the Company being able to complete and successfully integrate acquisitions, the Company being able to recognize and capitalize on opportunities and the Company continuing to attract qualified personnel to supports its development requirements. These assumptions, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: the Company’s ability to achieve its objectives, the Company successfully executing its growth strategy, the ability of the Company to obtain future financings or complete offerings on acceptable terms, failure to leverage the Company’s portfolio across entertainment and media platforms, dependence on the Company’s key personnel and general business, economic, competitive, political and social uncertainties. These risk factors are not intended to represent a complete list of the factors that could affect the Company which are discussed in the Company’s most recent MD&A. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. GameSquare assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.
Corporate Contact
Lou Schwartz, President Phone: (216) 464-6400 Email: ir@gamesquare.com
Delivering cost-effective simulation training solutions to improve proficiency and critical decision-making skills
SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 12, 2025 / Cubic Defense is proud to announce a strategic collaboration with ShootHouse and Digimation. The alliance will provide Cubic exclusivity for VIPER and DART MAX™ to customers in the Middle East and Singapore. Cubic will also provide tailor-made, in-country, operations and maintenance support to meet customer requirements.
“This collaboration reflects a shared commitment to equipping global law enforcement and military teams with the most advanced and effective training solutions,” said Alicia Combs, Vice President and General Manager at Cubic Defense. “The EST4000 capability delivers a tailor-made, cost-effective way to experience and learn from life-threatening situations in a safe environment to improve firearm proficiency and critical decision-making skills.”
EST4000 Standard (S): Based on ShootHouse’s VIPER software and integrated with best-in-class add-ons depending on the customer’s requirement (such as, tetherless recoil systems, shootback simulation, live fire options and weapon handling data capture).
EST4000 Live, Virtual and Constructive (LVC): Built on ShootHouse’s VIPER software and integrated to include a wide range of add-ons as set out for EST4000 (S). The system includes Cubic’s LVC training technology, providing exposure to a wide range of proficiencies, to deliver ultimate realism, including capabilities not previously available to simulation shooting ranges (including UAV, indirect weapon effects, electronic warfare, ISTAR, helicopters, and CCTV systems).
EST4000 Advanced (A): Created on Digimation’s DART MAX™ software and integrated to include a wide range of add-ons as set out for EST4000 (S). The system will include 4K resolution, computer generated imagery (CGI), extensive use of Artificial Intelligence (AI), Arabic language models and an unlimited ability to self-create and save scenarios and training activities. EST4000 (A) offers tailored, game-changing technology to the Middle East and Singapore with incredible AI growth opportunities.
To learn more about Cubic products and services, visit www.cubic.com.
About Cubic Cubic creates and delivers technology solutions in transportation that make people’s lives easier by simplifying their daily journeys, and defense capabilities that help promote mission success and safety for those who serve their nation. Led by our talented teams around the world, Cubic is driven to solve global challenges through innovation and service to our customers and partners.
Part of Cubic’s portfolio of businesses, Cubic Defense provides networked Command, Control, Communications, Computers, Cyber, Intelligence, Surveillance and Reconnaissance (C5ISR) solutions and is a leading provider of live, virtual, constructive and game-based training solutions for both U.S. and Allied Forces. These mission-inspired capabilities enable assured multi-domain access; converged digital intelligence; and superior readiness for defense, intelligence, security and commercial missions.
New agreement reinforces Formerra’s strategy to support high-performance applications with advanced polymer solutions across multiple markets.
ROMEOVILLE, IL / ACCESS Newswire / August 12, 2025 / Formerra, a leader in performance materials distribution, has signed an agreement with Syensqo to distribute its Solef® Polyvinylidene Fluoride (PVDF) materials in North America. The agreement expands access to this critical material known for its combination of chemical resistance and flexibility. Solef® PVDF joins a growing list of high-performance materials in Formerra’s portfolio designed to advance product development and innovation.
“With this new agreement, Formerra will be able to support customers across multiple markets with the materials they need to meet demanding application requirements,” said Bob Long, Business Development Manager at Formerra. “In addition, this reinforces our commitment to delivering unmatched access, application support, and advanced materials for customers navigating complex performance and regulatory challenges.”
PVDF is positioned near the top of the performance pyramid for its outstanding chemical and heat resistance. Its inherent flexibility further enhances its suitability for demanding applications in chemical processing, healthcare, and automotive industries. Key properties* include:
Heat resistance: Continuous use temperatures up to 150 °C (302 °F), bursting pressures of up to 139 bar (2,017 psi) at room temperature
Chemical purity: Ultra-pure water resistivity, meeting SEMI F-57 specifications for the semiconductor industry
Balance of strength and flexibility: Tensile yield strength up to 55 MPa (8,000 psi) with elongation at break up to 100%
“We chose Formerra as our distribution partner for Solef® PVDF in North America because of their technical and commercial reach,” said Rose Catherin, Sales Director Americas, Channel partners, Distribution and Digital Sales at Syensqo Specialty Polymers. “Their commitment to excellence and long-standing presence in critical markets make them an ideal fit to help expand the availability and use of Solef® PVDF.”
*As measured by TDS
Key Details:
Formerra is an authorized distributor of Solef® PVDF from Syensqo in North America.
The agreement includes support for high-performance applications across a broad spectrum of industries.
PVDF offers excellent chemical resistance, thermal stability, and flexibility.
Formerra provides technical guidance and supply chain expertise to support material selection and application development.
###
About Formerra Formerra is a preeminent distributor of engineered materials, connecting the world’s leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways – driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.
Philadelphia, PA – In the fight against human trafficking, few attorneys in Pennsylvania have demonstrated the level of commitment, legal knowledge, and survivor-focused advocacy as Ashley B. DiLiberto, Esq., managing attorney of Survivors of Abuse PA. Based in Philadelphia and serving clients across the state, DiLiberto has built a reputation as one of the leading civil attorneys representing survivors of sex trafficking. Her law firm has been recognized for providing trauma-informed legal support and pursuing aggressive civil litigation against traffickers and the institutions that enable them.
Sex trafficking is a devastating crime that targets the vulnerable, including minors, runaways, immigrants, and economically disadvantaged individuals. Victims are often manipulated, coerced, or forced into commercial sexual exploitation by traffickers who profit off their abuse. What many survivors do not know is that they may have the legal right to seek compensation from not only their traffickers, but also from third parties—such as hotels, motels, transportation services, websites, and landlords—who turned a blind eye or knowingly profited from trafficking activity. Under federal laws like the Trafficking Victims Protection Reauthorization Act (TVPRA), survivors have the right to file civil lawsuits against those who facilitated or failed to prevent the abuse.
Attorney Ashley B. DiLiberto has emerged as a powerful advocate in this space. She has worked with survivors to bring civil claims that shine a light on corporate negligence and institutional complicity. Whether the abuse occurred in a roadside motel, a rideshare vehicle, or behind closed doors in residential apartments, DiLiberto’s firm has the resources and experience to investigate trafficking networks and hold all responsible parties accountable.
What sets DiLiberto apart is her trauma-informed approach to the legal process. Her team understands the deep psychological impact that trafficking leaves on survivors and offers legal services grounded in empathy, trust, and confidentiality. Every case is handled with the utmost discretion, and clients are never pressured to share more than they are ready to. Survivors of Abuse PA also collaborates with therapists, victim advocates, and social workers to ensure clients receive holistic support throughout the legal journey.
Ashley B. DiLiberto has represented clients in high-profile sexual abuse cases and is no stranger to challenging litigation. She played a pivotal role in the historic Boy Scouts of America sexual abuse settlement and has been involved in multidistrict litigation representing survivors of institutional abuse. Her expertise in complex legal procedures, combined with her dedication to client welfare, makes her uniquely equipped to handle the intricate nature of sex trafficking lawsuits, which often involve multiple defendants and sensitive timelines.
In addition to her courtroom advocacy, DiLiberto is a public voice for reform. She supports legislative efforts to extend statutes of limitations and create “lookback windows” for survivors who were previously barred from filing claims. Her firm offers free and confidential consultations to anyone who believes they may have been sex trafficked and works on a contingency fee basis—meaning clients never pay out of pocket unless compensation is recovered.
Survivors of Abuse PA is headquartered at 123 S. 22nd Street in Philadelphia and proudly represents survivors throughout the entire state, including Pittsburgh, Allentown, Lancaster, Harrisburg, Erie, and Scranton. By combining legal strength with compassionate care, Ashley B. DiLiberto continues to set the standard for sex trafficking litigation in Pennsylvania. To learn more, give their Pennsylvania law office a call at (267) 502-9090.
Dr. Mark Hickman, a skilled surgeon in microsurgical vasectomy reversals from New Braunfels, Texas, is expanding his services to better serve patients traveling from various parts of the United States. With more than 26 years of experience, Dr. Hickman has successfully helped numerous individuals become parents after a vasectomy. His clinic is known for its focus on the patient, providing comprehensive and cost-effective care.
Those interested in learning more can explore Dr. Hickman’s website to find extensive information about his services. His vasectomy reversal procedure involves a precise microsurgical technique to repair the vas deferens. By using a top-tier operating microscope and fine nylon sutures, the method aims for precise alignment and a tight seal, boosting the chances of success. People interested in learning more can take advantage of a free consultation call to discuss their specific needs and get more details about the procedure.
“Our main goal is to help couples who have changed their minds about having children after a vasectomy,” said Dr. Mark Hickman, a microsurgical vasectomy reversal surgeon. “We are dedicated to providing high-quality surgical care that is effective and reachable for our patients, no matter where they are located.”
For those traveling from out of town, Dr. Hickman’s website provides key details about accommodations, ensuring the entire process is as smooth as possible by guiding patients to discounted hotel rates in New Braunfels. His office offers information regarding these arrangements to ease the travel process. This ensures that they can concentrate on their health and recovery without extra worries. Patients come not only from nearby states like Louisiana and Oklahoma but also from across the country for the excellent care and reasonable pricing offered by Dr. Hickman.
What stands out in Dr. Hickman’s practice is the transparency in pricing described on the website. He offers two all-inclusive packages for the procedure. Patients can choose a local anesthesia option at $3,300 or an IV sedation option, provided by a Board Certified Anesthesiologist, for $4,200. These packages ensure patients know their financial commitment right from the start with no hidden costs.
To reach a wider audience, Dr. Hickman’s website includes a detailed news section and a blog providing insights into the vasectomy reversal process. Visitors can read stories from past patients, check FAQs, and get the latest information about advancements in microsurgical techniques. This online resource helps those considering the procedure make informed decisions about their health.
“I am deeply invested in progressing the field of vasectomy reversal and improving our patients’ experiences,” Dr. Hickman stated. “We are dedicated to supporting our patients before, during, and after surgery, making sure they have all the resources they need.”
Through committed dedication and a caring approach to patient care, Dr. Mark Hickman microsurgical vasectomy reversal surgeon has earned a reputation as a leading figure in vasectomy reversal surgery. His practice exemplifies how specialized care, combined with patient-focused services, can effectively address the diverse needs of individuals and families.
Those interested in learning more about Dr. Mark Hickman’s services, including the microsurgical vasectomy reversal options, consultation information, and patient reviews, are welcome to visit the practice’s website. Dr. Hickman and his team are also available to answer questions or discuss scheduling over the phone or via email, ensuring patients have what they need to make confident healthcare choices. The FAQ section on his website also provides answers to common questions, offering a comprehensive look at the procedure.
Ginza Diamond Shiraishi Hong Kong, renowned for its heritage of precision craftsmanship rooted in Japanese tradition, is offering renewed insight into the historical, cultural, and symbolic meaning of the 鑽石戒指 (diamond ring) as it continues to evolve in modern society. While trends shift across global markets, the brand emphasizes the continued relevance of the diamond ring as a reflection of enduring commitments, shared values, and a growing appreciation for personal expression through fine jewelry.
The diamond ring, or 鑽石戒指, holds a profound place in the context of life’s most significant rituals. As a visual symbol of unity and trust, it often represents one of the first shared decisions a couple makes when committing to a future together. In both Western and Eastern cultures, the diamond ring signifies a promise of loyalty, of future, and of emotional permanence. Over time, its meaning has expanded to include individual stories, personal preferences, and evolving aesthetic sensibilities.
At Ginza Diamond Shiraishi Hong Kong, these layered meanings are respected through a design approach that centers not only on form and quality, but on relevance to the couple’s experience. The brand’s interpretation of 鑽石戒指 diamond rings is informed by the Japanese concept of “kizuna,” a word that implies the invisible yet powerful bonds between people. This philosophy is reflected in how the rings are conceptualized, from the initial sketch to the final polishing.
The design process integrates elements of nature, subtle symbolism, and balanced structure. Rather than adopting ornate or exaggerated detailing, Ginza Diamond Shiraishi focuses on quiet elegance. Curved lines may mirror the flow of a river or the gentle arc of a falling petal—symbolizing the natural, evolving rhythm of a relationship. Materials such as platinum are selected for their resilience and luster, while the diamonds themselves are meticulously evaluated for clarity, cut, and ethical sourcing.
Craftsmanship remains at the heart of the creation of each 鑽石戒指 diamond ring. Skilled artisans, many of whom have honed their expertise over decades, engage in a multi-step process that balances technical rigor with aesthetic sensibility. Every aspect of the ring’s structure is examined, from the diamond’s alignment and setting to the inner curvature of the band, which must remain comfortable for daily wear. The result is a ring that not only meets visual expectations but carries structural integrity capable of lasting through generations.
In the Hong Kong market, where a blend of cultural traditions, international influence, and personal style shapes consumer decisions, the diamond ring continues to evolve in both design and purpose. Younger generations, in particular, are expressing a preference for rings that align with individual identity while still honoring the ritualistic value attached to proposals and marriages. Ginza Diamond Shiraishi responds to this evolution through a design catalog that incorporates flexibility in customization, cultural sensibility, and symbolic depth.
Customer interaction also plays a significant role in the selection of a 鑽石戒指 diamond ring. The Hong Kong showroom is designed not merely as a retail space, but as an environment where thoughtful consultation can take place. Staff members are trained not just in jewelry knowledge but in the cultural and emotional considerations that often accompany the decision to purchase a diamond ring. Discussions often move beyond technical specifications, inviting customers to explore the story behind each design and its resonance with their personal journey.
The digital transformation of the jewelry-buying experience has also impacted how couples approach this decision. Ginza Diamond Shiraishi Hong Kong’s online platform enables users to view ring styles, explore meanings, and gather information in advance of in-person visits. This blend of digital accessibility and traditional service ensures that the process remains both informed and intimate.
Ethical sourcing is another critical consideration in the production of 鑽石戒指 diamond rings. Ginza Diamond Shiraishi maintains strict policies regarding conflict-free diamonds, fair labor practices, and environmentally responsible materials. These practices are in alignment with international standards and reflect a broader commitment to transparency, sustainability, and consumer trust.
From a cultural perspective, the act of giving a diamond ring continues to hold symbolic weight in Hong Kong and broader East Asia. The gesture is often seen not only as a romantic milestone but as a respectful acknowledgment of familial and social responsibility. In many cases, the ring serves as a bridge between modern partnership and ancestral tradition, connecting past values with future aspirations. Ginza Diamond Shiraishi Hong Kong is attentive to these nuances, offering design approaches that respect these traditions while allowing room for individuality.
In addition, the brand’s presence in Hong Kong allows it to serve as a cultural intermediary, introducing Japanese jewelry-making techniques and values to an international audience. This has positioned the company uniquely within the Asian bridal jewelry landscape, where authenticity and craftsmanship are increasingly favored over trends and mass production.
Looking forward, Ginza Diamond Shiraishi Hong Kong continues to view the 鑽石戒指 diamond ring not merely as a product but as a ceremonial object a tangible expression of emotional truth. As social norms and consumer expectations shift, the brand maintains its commitment to offering rings that balance elegance, meaning, and structural excellence. In a time when many personal traditions are being redefined, the diamond ring remains a singular object that carries universal resonance.
